Tag: APAS Independence
AstraZeneca backs LBT Innovations’ drug manufacturing AI development
LBT Innovations has partnered with AstraZeneca to develop artificial intelligence software that would be used in drug manufacturing.
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
